Test Your Knowledge of COPD Research Presented at CHEST!
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
A curated eBook featuring CHEST 2024 RCC-focused studies, findings, and expert opinions.
Do you remember the COPD research presented at CHEST 2024? Test your knowledge now and see how you rank!
A case from CHEST 2024 shows that cardiac sarcoidosis should be considered in patients aged less than 65 who have unexplained high-grade atrioventricular block.
Researchers at CHEST 2024 examined the feasibility and accuracy of AI in predicting ICU admission for patients with acute exacerbation of COPD.
Serum creatinine shows potential as a non-cardiac biomarker for assessing mortality risk among patients with pulmonary embolism.
In COPD, rural women continue to experience a higher burden than urban women regarding other health conditions, access to care, and poverty.
Even after treatment with inhaled corticosteroids alone or in combination with long-acting antagonists, lung function decline continues in uncontrolled asthma.
The following is a summary of "Determining the Impact of COVID-19 Infection on Patients...
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.